congenital heart desease. Patent ductus arteriosus
Conditions
Interventions
Intervention 1: The intervention group in this study is a patient with albumin concentration of 5% in prime solutions.First, the appropriate oxygenator is selected with the patient and is primed with
Sponsors
Shahid Rajae Cardiovascular and Research Center
Eligibility
Sex/Gender
All
Age
5 Days to 2 Years
Inclusion criteria
Inclusion criteria: Parental satisfaction regarding participation in research project Age 5 days to 2 years Weight less than or equal to 10 kg Patients candidated for open heart surgery Congenital anomaly of the heart Duration of cardiopulmonary bypass[ for at least one hour and maximum three hours
Exclusion criteria
Exclusion criteria: Deep hypothermia low cardiac output edema or ascites before surgery Infection and inflammation known a week before surgery emergency surgery Not consenting parents to enter the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Albumin. Timepoint: At the beginning of the study (before the study started) - Immediately in the intensive care unit - 24 hours later in the intensive care unit. Method of measurement: Albumin Measuring Laboratory Kit.;On fluid balance. Timepoint: At the beginning of the study (before the study started) - Immediately in the intensive care unit - 24 hours later in the intensive care unit. Method of measurement: Laboratory kit measuring body electrolytes. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmirhosein Salehzade
Shahid Rajae Cardiovascular and Research Center
Outcome results
None listed